William Blair Starts Larimar Therapeutics (LRMR) at Outperform
- S&P 500, Dow climb for third day and close at records
- Tesla (TSLA) China Numbers 'Robust' - Wedbush
- Apple (AAPL) Shares Seen as 'Attractive' as Recent Checks Show Continuously Strong Demand - Citi
- Amazon.com warehouse workers vote to reject forming union in Alabama
William Blair analyst Myles Minter initiates coverage on Larimar Therapeutics (NASDAQ: LRMR) with a Outperform rating.
Shares of Larimar Therapeutics closed at $15.71 yesterday.
You May Also Be Interested In
- UPDATE: DA Davidson Starts CuriosityStream Inc. (CURI) at Buy
- UPDATE: Goldman Sachs Starts Sealed Air (SEE) at Buy
- UPDATE: Goldman Sachs Starts Nucor (NUE) at Buy